ID

Inca Dieterich

Building @ ARCH Venture Partners | Co-Founder @ Vilya

United States

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

United States

  • Min Investment:

    $50,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Inca

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

AV
ARCH Venture Partners

2020

  • Venture Partner

    2024

    Source and evaluate investment opportunities across biotech and healthcare that have an outsized impact on human health. Create new ventures and operate within portfolio companies.

  • Associate

    2020 - 2024

V
Vilya

2022

  • Co-Founder, and VP, Business Development

    2024

    At Vilya, we are creating a novel class of medicines to precisely target disease biology.

  • Co-Founder and Head, Business Operations

    2022 - 2024

RC
Rippl Care

2021

  • Co-Founder and VP, Strategy & Innovation

    2021

FP
Flagship Pioneering

2020 - 2020

  • VentureLabs Fellow

    2020 - 2020

Uo
University of Wisconsin-Madison

2015 - 2020

  • Biochemical Neuroscientist | PhD

    2015 - 2020

W
WiSolve

2019 - 2020

  • Consultant & Board Member

    2019 - 2020

Idaho Bioscience

2012 - 2015

  • R&D Research Scientist

    2012 - 2015

NJ
NASA Jet Propulsion Laboratory

2012 - 2012

  • Independent Research Intern

    2012 - 2012

Uo
University of California, Los Angeles

2011 - 2012

  • Research Collaborator

    2011 - 2012